Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan H Moore

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Plos One|July 11, 2013
Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cellsAejaz Sayeed, Gloria Luciani-Torres, Zhenhang Meng, et al.
Cancer Research|February 28, 2002
Increased risk of local recurrence is associated with allelic loss in normal lobules of breast cancer patientsZheng Li, Dan H Moore, Zhen Hang Meng, et al.
Patient Education and Counseling|June 14, 2011
Impact of decision aids in a sustained implementation at a breast care centerJeffrey K Belkora, Shelley Volz, Alexandra E Teng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Alteration of gene expression in macroscopically normal colonic mucosa from individuals with a family history of sporadic colon cancerChun-Yi Hao, Dan H Moore, Patrick Wong, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2008
Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin usersAnjali S Kumar, Christopher C Benz, Veronica Shim, et al.
Alternative Therapies in Health and Medicine|November 30, 2006
The efficacy of distant healing for human immunodeficiency virus--results of a randomized trialJohn A Astin, Jerome Stone, Donald I Abrams, et al.
Carcinogenesis|September 6, 2011
Activation of the mTOR pathway by low levels of xenoestrogens in breast epithelial cells from high-risk womenWilliam H Goodson, Maria Gloria Luciani, S Aejaz Sayeed, et al.
BMC Cancer|April 30, 2009
Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosisJeffrey K Belkora, Hope S Rugo, Dan H Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2007
Ductal carcinoma in situ in BRCA mutation carriersE Shelley Hwang, Jane L McLennan, Dan H Moore, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 11, 2012
Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE studyDejana Braithwaite, Dan H Moore, William A Satariano, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Plos One|July 11, 2013
Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cellsAejaz Sayeed, Gloria Luciani-Torres, Zhenhang Meng, et al.
Cancer Research|February 28, 2002
Increased risk of local recurrence is associated with allelic loss in normal lobules of breast cancer patientsZheng Li, Dan H Moore, Zhen Hang Meng, et al.
Patient Education and Counseling|June 14, 2011
Impact of decision aids in a sustained implementation at a breast care centerJeffrey K Belkora, Shelley Volz, Alexandra E Teng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Alteration of gene expression in macroscopically normal colonic mucosa from individuals with a family history of sporadic colon cancerChun-Yi Hao, Dan H Moore, Patrick Wong, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2008
Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin usersAnjali S Kumar, Christopher C Benz, Veronica Shim, et al.
Alternative Therapies in Health and Medicine|November 30, 2006
The efficacy of distant healing for human immunodeficiency virus--results of a randomized trialJohn A Astin, Jerome Stone, Donald I Abrams, et al.
Carcinogenesis|September 6, 2011
Activation of the mTOR pathway by low levels of xenoestrogens in breast epithelial cells from high-risk womenWilliam H Goodson, Maria Gloria Luciani, S Aejaz Sayeed, et al.
BMC Cancer|April 30, 2009
Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosisJeffrey K Belkora, Hope S Rugo, Dan H Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2007
Ductal carcinoma in situ in BRCA mutation carriersE Shelley Hwang, Jane L McLennan, Dan H Moore, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 11, 2012
Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE studyDejana Braithwaite, Dan H Moore, William A Satariano, et al.
Pageof 11